Objective: To investigate the use of a biologic TNF-alpha inhibitor, etanercept was given by perispinal extrathecal administration for the treatment of AD. Methods: This was a prospective ...
Verywell Health on MSN12mon
An Overview of Biologics for Crohn’s TreatmentMedically reviewed by Lindsay Cook, PharmD Biologic medical therapies, or biologics, are an important type of treatment for ...
TNF Pharmaceuticals (TNFA) announced the initiation of a fully funded Phase 2b clinical trial evaluating oral TNF-alpha inhibitor drug ...
TNF Pharmaceuticals (TNFA) announced that data from the Phase 2a clinical trial of its oral TNF-alpha inhibitor drug candidate isomyosamine was ...
In vitro tests indicate that cannabidiol can stimulate the biomineralization of teeth even under inflammatory conditions, ...
BALTIMORE--(BUSINESS WIRE)--TNF Pharmaceuticals ... its novel oral TNF-alpha (TNF-α) inhibitor drug, isomyosamine, in preserving lean muscle mass during and after GLP-1 treatment for weight ...
Hypothalamic inflammation, indicated by tumor necrosis factor (TNF)-α expression ... (i.p.) glucose tolerance test after 7 weeks of treatment. Mice were fasted for 6 h, and the tests were ...
Treatment with deucravacitinib in patients with active PsA showed higher response rates and improvement in quality of life ...
TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback